ProVerum and Zenflow both this week announced FDA approvals for their technologies that treat benign prostatic hyperplasia ...
U.S. Food and Drug Administration (FDA) approval of the Zenflow Spring® Implant and Delivery System for the treatment of symptoms associated with benign prostatic hyperplasia (BPH), also known as ...
A new, low-maintenance implant device is now available to residents facing incontinence issues, adding freedom back to the ...
A new, low-maintenance implant device is now available to residents facing incontinence issues, adding freedom back to the ...
St. Bernards Healthcare introduces Arkansas’s first FDA-approved, anesthesia-free tibial nerve implant for overactive bladder, offering same-day therapy with long-lasting, minimally invasive relief.
St. Bernards Healthcare has implanted Arkansas’s first Altaviva™ tibial nerve device, offering a minimally invasive, ...
Muvon Therapeutics has linked its cell therapy to a 60% drop in stress incontinence episode frequency in a small phase 2 ...
DOWNERS GROVE, IL / ACCESS Newswire / December 2, 2025 / Dr. Sarah Martin, a women's urology specialist at Duly Health and ...
Researchers have identified a promising alternative material for treating the condition of stress urinary incontinence.
A new bladder cancer treatment called TAR-200 has shown impressive results in a recent clinical trial. The study found that 82% of patients with high-risk non-muscle-invasive bladder cancer had their ...
To make life easier for people with a common bladder condition, Medtronic is digging in far away from urinary tract. Treatment for urinary urge incontinence can require pads, absorbent underwear and ...
Bladder control problems affect an estimated 43 million – or one in six – U.S. adults. Of those, nearly 16 million people have urge urinary incontinence, a common symptom of overactive bladder (OAB) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results